Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Efficacy and Safety of XC8 in Patients With the Eosinophilic Phenotype of Bronchial Asthma

NCT04674137 is registered in ClinicalTrials.gov with Chemlmmune Therapeutics LLC as lead sponsor.

NCT NCT04674137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04674137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Efficacy and Safety of XC8 in Patients With the Eosinophilic Phenotype of Bronchial Asthma
Lead sponsor
Chemlmmune Therapeutics LLC
Phase
Phase 2
Overall status
Completed
Start date
December 16, 2020
Completion date
August 27, 2021
Enrollment
70 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial asthma, eosinophilic asthma